Provided by Tiger Trade Technology Pte. Ltd.

CANBRIDGE-B

2.650
-0.370-12.25%
Volume:3.15M
Turnover:8.68M
Market Cap:1.35B
PE:-2.54
High:3.000
Open:3.000
Low:2.650
Close:3.020
52wk High:3.500
52wk Low:0.123
Shares:511.00M
HK Float Shares:511.00M
Volume Ratio:0.27
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.042
ROE:-281.91%
ROA:-57.53%
PB:-2.92
PE(LYR):-2.54
PS:19.11

Loading ...

CANbridge Pharmaceuticals Inc. (1228) Releases Supplemental Details on Share Options and RSUs

Bulletin Express
·
Yesterday

CANbridge Pharmaceuticals Issues Supplemental Disclosure on Share Option and RSU Grants

Reuters
·
Yesterday

BUZZ-CANbridge Pharmaceuticals jumps as WuXi Biologics buys shares

Reuters
·
Feb 16

CANBRIDGE-B Soars Over 17% in Morning Session Following Discounted Share Placement Raising Over HK$200 Million

Deep News
·
Feb 16

CANBRIDGE-B Shares Surge Following Discounted Share Placement

Stock News
·
Feb 16

BRIEF-Canbridge Pharmaceuticals Inc To Issue Aggregate Of 84 Million Subscription Shares

Reuters
·
Feb 16

CANbridge Pharmaceuticals Inc. (1228) and WuXi Biologics Healthcare Venture Agree HK$200.00 Million New Share Subscription

Bulletin Express
·
Feb 16

CANBRIDGE-B Announces Private Placement of 84.03 Million Shares at a 14.70% Discount to Raise Approximately HK$199 Million

Stock News
·
Feb 16

Canbridge Pharmaceuticals Announces HK$2.38 Share Private Placement

Reuters
·
Feb 16

CANbridge Pharmaceuticals Inc. (01228) Announces 102,000 New Shares Issued for January 2026

Bulletin Express
·
Feb 05

CANBRIDGE-B (01228) Grants Approximately 6.37 Million Share Options and an Equal Number of Restricted Share Units

Stock News
·
Jan 12

Canbridge Pharmaceuticals Grants Share Options and Restricted Share Units to Directors and Employees

Reuters
·
Jan 12

Individual investors are CANbridge Pharmaceuticals Inc.'s (HKG:1228) biggest owners and were hit after market cap dropped HK$138m

Simply Wall St.
·
Dec 20, 2025

CANBRIDGE-B (01228) Self-Developed CAN 103 Included in China's First "Commercial Insurance Innovative Drug Directory"

Stock News
·
Dec 08, 2025

Canbridge Pharmaceuticals' CAN 103 Approved for China’s Innovative Drug List

Reuters
·
Dec 08, 2025

CANbridge Pharmaceuticals - Can 103 Included in China's Innovative Drug List

THOMSON REUTERS
·
Dec 08, 2025

Canbridge Pharmaceuticals Inc. held extraordinary general meeting

Reuters
·
Dec 04, 2025

CANbridge Pharmaceuticals Inc. (01228) Announces November 2025 Monthly Return, Share Capital Remains Unchanged

Bulletin Express
·
Dec 04, 2025

Hong Kong Stock Investment Diary | December 1, 2025

Stock News
·
Dec 01, 2025

CANbridge Pharmaceuticals Inc. (1228) Calls Extraordinary General Meeting on December 4, 2025

Bulletin Express
·
Nov 19, 2025